fbpx
维基百科

苯二氮䓬类药物戒斷症候群

十月 19, 2023

维基百科中的醫學内容仅供参考，並不能視作專業意見。如需獲取醫療幫助或意見，请咨询专业人士。詳見醫學聲明。

苯二氮䓬类药物戒斷症候群又称苯二氮卓戒断综合征（英語：Benzodiazepine withdrawal syndrome），通常缩写为苯并戒断（benzo withdrawal）或BZD戒断（BZD withdrawal） ，是指服用苯二氮䓬类药物（可能因医疗原因或娱乐性原因用药）并产生生理依赖性后，减少用量或停药时产生的藥物戒斷症状。觅药行为或按处方服药均可能导致生理依赖性与药物成瘾（或二者之一）以及因此产生的戒断症状。某些症状可能持续数年。苯二氮䓬类药物戒斷症候群的显著特征症状包括：睡眠障碍、易怒、紧张焦虑、恐慌發作、手颤、发抖、出汗、难以集中精神、意识混乱和认知障碍、记忆减退、恶心干呕、体重下降、心悸、头痛、肌肉疼痛僵硬、知觉变化、幻觉、癲癇發作、思覺失調[1]以及自杀[2][3]。此外，这些症状可能时好时坏，每日或每周的严重程度不一，而不是持续稳定好转。[4]

苯二氮䓬类药物戒斷症候群
类型戒断状态[*], 苯二氮䓬类药物依赖性
分类和外部资源
醫學專科精神病学
ICD-10F13.3 （持续用药后）
[编辑此条目的维基数据]

苯二氮䓬类戒断症状可能很严重，症状复杂且常常长期持续。[5][6]长期使用苯二氮䓬类（即每日用药，持续至少三个月）[7]可能有更高的药物依赖风险[8]，亦可能造成用量增加、药效降低、增加事故和摔倒的概率（尤其是老年人），[9]还可能与认知、[10]神经系统和智力损伤有关[11]。因此不宜长期使用苯二氮䓬类药物。[8]将苯二氮䓬类药物作为短效安眠药使用，在入睡时可能有效，但可能因戒断反应而导致后半段睡眠质量不佳。[12]尽管如此，对于长期服用苯二氮䓬类药物者，不应违背其意愿强迫停药。[5]

苯二氮䓬类戒断可能有重症反应，甚至产生癫痫发作等危及生命的症状，[13]尤其是突然戒断或减量过快的大剂量或长期用药者。[5]然而逐步减量或相对用量较少的短期用药者亦可能出现重症戒断反应，[14]在动物模型中甚至曾有单次大剂量用药后戒断出现重症反应。[15][16]少数人会出现遷延性戒斷症狀（英语：post-acute-withdrawal syndrome），症状可能在戒断后数月甚至数年内持续，维持在亚急性状态。缓慢而逐步的减少药物用量能使遷延性戒斷症狀的出现概率尽可能降低。[17]

长期使用苯二氮䓬类药物会导致神经适应，降低药物效果，造成耐受和依赖。[18]即使是持续服用治疗剂量期间，长期使用苯二氮䓬类药物亦可能引起类似戒断反应的症状，尤其是在服药间隔期。[19]停药或减少用量后，用药者即会出现药物戒断症状，直至其生理适应恢复。[20]这些反跳症状（英语：Rebound effect）可能与最初服药前的病症相同，亦可能是戒斷症候群的一部分。[21]在重症病例中，戒断反应可能会恶化，或与严重的精神疾病相似，如狂躁、精神分裂症，尤其在大剂量用药者中还会出现癲癇重積狀態。[22]若不能正确诊断出戒斷症候群，可能会误诊为服药前的疾病复发而需要继续用药，导致戒断失败、重新开始用药，而重新用药往往比之前的剂量更大。[22]

提高戒断成功率的方法包括：提升对戒断反应的意识，针对用药者的戒断反应严重程度而制定个人化的逐步戒断方法，以及增加其他替代方法辅助，如使用药者安心、参加苯二氮䓬类药物戒断互助小组。这些方法都能有效提高戒断的成功率。[23][24]

症状和体征 编辑

 
地西泮，其2毫克与5毫克片剂常用于治疗苯二氮䓬类戒断反应[25]
 
氯二氮平（英语：Chlordiazepoxide），其5毫克胶囊剂有时可作为地西泮的替代药物，用于治疗苯二氮䓬类戒断反应。氯二氮平与地西泮都有较长的消除半衰期和长效活性代謝產物

苯二氮䓬类、巴比妥类等镇静安眠药物或酒精成瘾者在停用后会产生严重的戒断反应症状。《临床成人精神医学手册》显示这些戒断症状比鸦片类药物的戒断症状更严重、危害更大。[26]使用者在停药时一般甚少获得相关建议和支持。[27]一些戒断症状与用药治疗之前的病症相同，[21]可能症状严重或长期持续。半衰期较长的苯二氮䓬类药物可能在停用长达三周之后才会出现戒断反应，而半衰期较短的药物则较早出现戒断反应，一般在停用24-48小时后即会出现。[28]不同剂量用药者的戒断症状种类可能没有重大差异，但大剂量用药者的症状严重程度往往更高。[29]

在用药量减少时，服药者可能会首次出现戒断反应，包括失眠、焦虑、痛苦、体重下降、晕眩、夜汗、肌肉抽搐、恐慌发作、抑郁、失实症、偏执等。这些症状更常见于短效苯二氮䓬类停药时，例如三唑仑等药物。[22][30]日间症状可能在夜间用药给药数日至数周后出现，[31][32]亦可能出现于佐匹克隆等Z药物使用者。[33]即使是间歇服用苯二氮䓬类，[34]亦可能在戒断后出现失眠症状反弹，可能比服药前更加严重。[35][36]

逐步或突然减少药量可能出现下列症状：

迅速停药可能会引发更严重的症状：

参考来源 编辑

  1. ^ 1.0 1.1 1.2 1.3 1.4 Petursson, H. The benzodiazepine withdrawal syndrome. Addiction. 1994, 89 (11): 1455–9. PMID 7841856. doi:10.1111/j.1360-0443.1994.tb03743.x. 
  2. ^ 2.0 2.1 2.2 Colvin, Rod. Overcoming Prescription Drug Addiction: A Guide to Coping and Understanding 3. United States of America: Addicus Books. 26 August 2008: 74–76. ISBN 978-1-886039-88-9. I have treated ten thousand patients for alcohol and drug problems and have detoxed approximately 1,500 patients for benzodiazepines – the detox for the benzodiazepines is one of the hardest detoxes we do. It can take an extremely long time, about half the length of time they have been addicted – the ongoing relentless withdrawals can be so incapacitating it can cause total destruction to one’s life – marriages break up, businesses are lost, bankruptcy, hospitalization, and of course suicide is probably the most single serious side effect. 
  3. ^ 3.0 3.1 3.2 Dodds TJ. Prescribed Benzodiazepines and Suicide Risk: A Review of the Literature. Primary Care Companion for CNS Disorders. 2017, 19 (2). PMID 28257172. doi:10.4088/PCC.16r02037. 
  4. ^ C. Heather Ashton DM. Chapter III: Benzodiazepine withdrawal symptoms, acute & protracted. Institute of Neuroscience, Newcastle University. [29 April 2013]. （原始内容于2019-04-04）. Benzodiazepines : How they work and how to withdraw 
  5. ^ 5.0 5.1 5.2 5.3 Professor Heather Ashton. Benzodiazepines: How They Work and How to Withdraw. 2002 [2018-04-02]. （原始内容存档于2012-10-18）. 
  6. ^ O'Connor, RD. Benzodiazepine dependence--a treatment perspective and an advocacy for control. NIDA research monograph. 1993, 131: 266–9. PMID 8105385. 
  7. ^ Voshaar, R. C. O.; Couvée, JE; Van Balkom, AJ; Mulder, PG; Zitman, FG. Strategies for discontinuing long-term benzodiazepine use: Meta-analysis. British Journal of Psychiatry. 2006, 189 (3): 213–20. PMID 16946355. doi:10.1192/bjp.189.3.213. 
  8. ^ 8.0 8.1 Nutt, David. Benzodiazepine dependence in the clinic: Reason for anxiety?. Trends in Pharmacological Sciences. 1986, 7: 457–60. doi:10.1016/0165-6147(86)90420-7. 
  9. ^ De Gier, N.; Gorgels, W.; Lucassen, P.; Oude Voshaar, R.; Mulder, J.; Zitman, F. Discontinuation of long-term benzodiazepine use: 10-year follow-up. Family Practice. 2010, 28 (3): 253–9. PMID 21193495. doi:10.1093/fampra/cmq113. 
  10. ^ Authier, Nicolas; Boucher, Alexandra; Lamaison, Dominique; Llorca, Pierre-Michel; Descotes, Jacques; Eschalier, Alain. Second Meeting of the French CEIP (Centres d'Évaluation et d'Information sur la Pharmacodépendance). Part II: Benzodiazepine Withdrawal. Thérapie. 2009, 64 (6): 365–70. PMID 20025839. doi:10.2515/therapie/2009051. 
  11. ^ Heberlein, A.; Bleich, S.; Kornhuber, J.; Hillemacher, T. Benzodiazepin-Abhängigkeit: Ursachen und Behandlungsmöglichkeiten [Benzodiazepine Dependence: Causalities and Treatment Options]. Fortschritte der Neurologie · Psychiatrie. 2008, 77 (1): 7–15. PMID 19101875. doi:10.1055/s-0028-1100831 （德语）. 
  12. ^ Lee-chiong, Teofilo. Sleep Medicine: Essentials and Review. Oxford University Press, USA. 24 April 2008: 468. ISBN 0-19-530659-7. 
  13. ^ Evans, Katie; Sullivan, Michael J. Withdrawal and Medical Issues. Dual Diagnosis: Counseling the Mentally Ill Substance Abuser 2nd. Guilford Press. 2001: 52–3 [2018-04-02]. ISBN 978-1-57230-446-8. （原始内容于2018-05-03）. 
  14. ^ Lader, M. Long-term anxiolytic therapy: The issue of drug withdrawal. The Journal of Clinical Psychiatry. 1987,. 48 Suppl: 12–6. PMID 2891684. 
  15. ^ Boisse, NR; Periana, RM; Guarino, JJ; Kruger, HS; Samoriski, GM. Pharmacologic characterization of acute chlordiazepoxide dependence in the rat. Journal of Pharmacology and Experimental Therapeutics. 1986, 239 (3): 775–83. PMID 3098961. 
  16. ^ Boisse, NR; Periana, RM; Guarino, JJ; Kruger, HS. Acute chlordiazepoxide dependence in the rat: Comparisons to chronic. NIDA research monograph. 1986, 67: 197–201. PMID 3092067. 
  17. ^ 17.0 17.1 Professor Heather Ashton. Protracted Withdrawal Symptoms From Benzodiazepines. Comprehensive Handbook of Drug & Alcohol Addiction. 2004 [2018-04-02]. （原始内容于2020-09-28）.  引用错误：带有name属性“pwsfb”的<ref>标签用不同内容定义了多次
  18. ^ Allison, C; Pratt, J.A. Neuroadaptive processes in GABAergic and glutamatergic systems in benzodiazepine dependence. Pharmacology & Therapeutics. 2003, 98 (2): 171–95. PMID 12725868. doi:10.1016/S0163-7258(03)00029-9. 
  19. ^ Herman, JB; Brotman, AW; Rosenbaum, JF. Rebound anxiety in panic disorder patients treated with shorter-acting benzodiazepines. The Journal of Clinical Psychiatry. 1987,. 48 Suppl: 22–8. PMID 2889722. 
  20. ^ Allgulander, C; Bandelow, B; Hollander, E; Montgomery, SA; Nutt, DJ; Okasha, A; Pollack, MH; Stein, DJ; Swinson, RP; World Council Of, Anxiety. WCA recommendations for the long-term treatment of generalized anxiety disorder. CNS Spectrums. 2003, 8 (8 Suppl 1): 53–61. PMID 14767398. 
  21. ^ 21.0 21.1 Salzman, Carl. Benzodiazepine treatment of panic and agoraphobic symptoms: Use, dependence, toxicity, abuse. Journal of Psychiatric Research. 1993, 27: 97–110. PMID 7908335. doi:10.1016/0022-3956(93)90021-S. 
  22. ^ 22.0 22.1 22.2 22.3 Gabbard, Glen O. Gabbard's Treatments of Psychiatric Disorders, Fourth Edition (Treatments of Psychiatric Disorders). American Psychiatric Publishing. 15 May 2007: 209–211. ISBN 1-58562-216-8. 
  23. ^ Onyett, SR. The benzodiazepine withdrawal syndrome and its management. The Journal of the Royal College of General Practitioners. 1989, 39 (321): 160–3. PMC 1711840  . PMID 2576073. 
  24. ^ 24.0 24.1 24.2 Ashton, Heather. Protracted withdrawal syndromes from benzodiazepines. Journal of Substance Abuse Treatment. 1991, 8 (1–2): 19–28. PMID 1675688. doi:10.1016/0740-5472(91)90023-4. 
  25. ^ 25.0 25.1 25.2 25.3 Soyka M. Treatment of Benzodiazepine Dependence. The New England Journal of Medicine. 2017, 376 (12): 1147–1157. PMID 28328330. doi:10.1056/NEJMra1611832. 
  26. ^ Lindsay, S. J. E. The Handbook of Clinical Adult Psychology. Psychology Press. 1994: 363 [2018-04-05]. ISBN 9780415072168. （原始内容于2019-09-05）. 
  27. ^ Authier, N.; Balayssac, D.; Sautereau, M.; Zangarelli, A.; Courty, P.; Somogyi, A.A.; Vennat, B.; Llorca, P.-M.; Eschalier, A. Benzodiazepine dependence: Focus on withdrawal syndrome. Annales pharmaceutiques françaises. 2009, 67 (6): 408–13. PMID 19900604. doi:10.1016/j.pharma.2009.07.001. 
  28. ^ Committee on Safety of Medicines. Hypnotics and anxiolytics. British National Formulary. 2007 [17 September 2007].  
  29. ^ Murphy, S. M.; Tyrer, P. A double-blind comparison of the effects of gradual withdrawal of lorazepam, diazepam and bromazepam in benzodiazepine dependence. British Journal of Psychiatry. 1991, 158 (4): 511–6. PMID 1675901. doi:10.1192/bjp.158.4.511. 
  30. ^ Adam, Kirstine; Oswald, I. Can a Rapidly-eliminated Hypnotic Cause Daytime Anxiety?. Pharmacopsychiatry. 2008, 22 (3): 115–9. PMID 2748714. doi:10.1055/s-2007-1014592. 
  31. ^ Scharf, Martin B; Kales, Judith A; Bixler, EO; Jacoby, JA; Schweitzer, PK. Lorazepam—Efficacy, side effects, and rebound phenomena. Clinical Pharmacology & Therapeutics. 1982, 31 (2): 175–9. PMID 6120058. doi:10.1038/clpt.1982.27. 
  32. ^ Walsh, James K; Schweitzer, Paula K; Parwatikar, Sadashiv. Effects of lorazepam and its withdrawal on sleep, performance, and subjective state. Clinical Pharmacology & Therapeutics. 1983, 34 (4): 496–500. PMID 6617072. doi:10.1038/clpt.1983.203. 
  33. ^ Fontaine, Réjean; Beaudry, Paul; Le Morvan, Patrick LE; Beauclair, Linda; Chouinard, GUY. Zopiclone and Triazolam in Insomnia Associated with Generalized Anxiety Disorder. International Clinical Psychopharmacology. 1990, 5 (3): 173–83. PMID 2230061. doi:10.1097/00004850-199007000-00002. 
  34. ^ Kales, Anthony; Manfredi, Rocco L; Vgontzas, Alexandras N; Bixler, Edward O; Vela-Bueno, Antonio; Fee, Eric C. Rebound insomnia after only brief and intermittent use of rapidly eliminated benzodiazepines. Clinical Pharmacology & Therapeutics. 1991, 49 (4): 468–76. PMID 2015735. doi:10.1038/clpt.1991.55. 
  35. ^ Kales, Anthony; Bixler, Edward O.; Soldatos, Constantin R.; Jacoby, Judith A.; Kales, Joyce D. Lorazepam: Effects on Sleep and Withdrawal Phenomena. Pharmacology. 1986, 32 (3): 121–30. PMID 3960963. doi:10.1159/000138160. 
  36. ^ Bonnet, M H; Arand, D L. The use of lorazepam TID for chronic insomnia. International Clinical Psychopharmacology. 1999, 14 (2): 81–9. PMID 10220122. doi:10.1097/00004850-199903000-00004. 
  37. ^ 37.00 37.01 37.02 37.03 37.04 37.05 37.06 37.07 37.08 37.09 37.10 37.11 37.12 37.13 37.14 37.15 Saxon, L.; Hjemdahl, P.; Hiltunen, A. J.; Borg, S. Effects of flumazenil in the treatment of benzodiazepine withdrawal - a double-blind pilot study. Psychopharmacology. 1997, 131 (2): 153–60. PMID 9201803. doi:10.1007/s002130050278. 
  38. ^ Terao, T; Yoshimura, R; Terao, M; Abe, K. Depersonalization following nitrazepam withdrawal. Biological Psychiatry. 1992, 31 (2): 212–3. PMID 1737083. doi:10.1016/0006-3223(92)90209-I. 
  39. ^ Lader, Malcolm. Anxiety or depression during withdrawal of hypnotic treatments. Journal of Psychosomatic Research. 1994, 38: 113–23; discussion 118–23. PMID 7799243. doi:10.1016/0022-3999(94)90142-2. 
  40. ^ 40.0 40.1 40.2 40.3 Mintzer, M. Z.; Stoller, K. B.; Griffiths, R. R. A controlled study of flumazenil-precipitated withdrawal in chronic low-dose benzodiazepine users. Psychopharmacology. 1999, 147 (2): 200–9. PMID 10591888. doi:10.1007/s002130051161. 
  41. ^ Mendelson, WB; Weingartner, H; Greenblatt, DJ; Garnett, D; Gillin, JC. A clinical study of flurazepam. Sleep. 1982, 5 (4): 350–60. PMID 6761826. 
  42. ^ Schöpf, J. Withdrawal Phenomena after Long-term Administration of Benzodiazepines a Review of Recent Investigations. Pharmacopsychiatry. 2008, 16 (1): 1–8. PMID 6131447. doi:10.1055/s-2007-1017439. 
  43. ^ Mintzer, Miriam Z.; Griffiths, Roland R. Flumazenil-precipitated withdrawal in healthy volunteers following repeated diazepam exposure. Psychopharmacology. 2004, 178 (2–3): 259–67. PMID 15452683. doi:10.1007/s00213-004-2009-1. 
  44. ^ Biswas, AK; Feldman, BL; Davis, DH; Zintz, EA. Myocardial ischemia as a result of severe benzodiazepine and opioid withdrawal. Clinical Toxicology. 2005, 43 (3): 207–9. PMID 15902797. doi:10.1081/clt-200053099. 
  45. ^ 45.0 45.1 45.2 45.3 45.4 Bismuth, C; Le Bellec, M; Dally, S; Lagier, G. Benzodiazepine physical dependence. 6 cases (author's transl). La Nouvelle presse medicale. 1980, 9 (28): 1941–5. PMID 6106922. 
  46. ^ 46.0 46.1 Loeb, P; Adnet, P; Boittiaux, P; Forget, AP; Mille, FX. Sevrage en benzodiazépines révélé par un syndrome douloureux abdominal pseudochirurgical [Benzodiazepine withdrawal masquerading as surgical abdominal syndrome]. Annales Françaises d'Anesthésie et de Réanimation. 1997, 16 (5): 521–2. doi:10.1016/S0750-7658(97)83345-X （法语）. 
  47. ^ BENZODIAZEPINE WITHDRAWAL SYMPTOMS, ACUTE AND PROTRACTED. Benzo.org.uk. [2018-04-05]. （原始内容于2019-04-04）. 
  48. ^ 48.0 48.1 48.2 48.3 48.4 Pelissolo, A; Bisserbe, JC. Dependence on benzodiazepines. Clinical and biological aspects. L'Encéphale. 1994, 20 (2): 147–57. PMID 7914165. 
  49. ^ Pecknold, J.C. Discontinuation reactions to alprazolam in panic disorder. Journal of Psychiatric Research. 1993, 27: 155–170. doi:10.1016/0022-3956(93)90025-W. 
  50. ^ Kliniska Färdigheter: Informationsutbytet Mellan Patient Och Läkare, LINDGREN, STEFAN, ISBN 91-44-37271-X (Swedish)[页码请求]
  51. ^ Drummond, Lynne M.; Matthews, Helen P. SINGLE CASE STUDY Obsessive-Compulsive Disorder Occurring as a Complication in Benzodiazepine Withdrawal. Journal of Nervous and Mental Disease. 1988, 176 (11): 688–91. PMID 3183654. doi:10.1097/00005053-198811000-00008. 
  52. ^ Matthews, HP; Drummond, LM. Obsessive-compulsive disorder--a complication of benzodiazepine withdrawal. British Journal of Psychiatry. 1987, 150: 272. PMID 3651695. doi:10.1192/s0007125000122810. 
  53. ^ Shader, RI; Greenblatt, DJ. The use of benzodiazepines in clinical practice. British Journal of Clinical Pharmacology. 1981,. 11 Suppl 1 (Suppl 1): 5S–9S. PMC 1401641  . PMID 6133535. doi:10.1111/j.1365-2125.1981.tb01832.x. 
  54. ^ Pagel, J. F.; Parnes, Bennett L. Medications for the Treatment of Sleep Disorders. Primary Care Companion to the Journal of Clinical Psychiatry. 2001, 3 (3): 118–125. PMC 181172  . PMID 15014609. doi:10.4088/PCC.v03n0303. 
  55. ^ Van Engelen, BG; Gimbrere, JS; Booy, LH. Benzodiazepine withdrawal reaction in two children following discontinuation of sedation with midazolam. Annals of Pharmacotherapy. 1993, 27 (5): 579–81. PMID 8347907. doi:10.1177/106002809302700509. 
  56. ^ Beeley, L. Benzodiazepines and tinnitus. BMJ. 1991, 302 (6790): 1465. doi:10.1136/bmj.302.6790.1465. 
  57. ^ Mellor, CS; Jain, VK. Diazepam withdrawal syndrome: Its prolonged and changing nature. Canadian Medical Association Journal. 1982, 127 (11): 1093–6. PMC 1862031  . PMID 7139456. 
  58. ^ Olajide, Dele; Lader, Malcolm. Depression following withdrawal from long-term benzodiazepine use: A report of four cases. Psychological Medicine. 2009, 14 (4): 937–40. PMID 6152745. doi:10.1017/S0033291700019899. 
  59. ^ Rosebush, Patricia I.; Mazurek, Michael F. Catatonia After Benzodiazepine Withdrawal. Journal of Clinical Psychopharmacology. 1996, 16 (4): 315–9. PMID 8835707. doi:10.1097/00004714-199608000-00007. 
  60. ^ Deuschle, M.F.; Lederbogen, F. Benzodiazepine Withdrawal - Induced Catatonia. Pharmacopsychiatry. 2001, 34 (1): 41–2. PMID 11229621. doi:10.1055/s-2001-15188. 
  61. ^ Kanemoto, Kousuke; Miyamoto, Toshio; Abe, Ryuji. Ictal catatonia as a manifestation of de novo absence status epilepticus following benzodiazepine withdrawal. Seizure. 1999, 8 (6): 364–6. PMID 10512781. doi:10.1053/seiz.1999.0309. 
  62. ^ Metten, Pamela; Crabbe, John C. Genetic Determinants of Severity of Acute Withdrawal from Diazepam in Mice. Pharmacology Biochemistry and Behavior. 1999, 63 (3): 473–9. PMID 10418790. doi:10.1016/S0091-3057(99)00017-9. 
  63. ^ Haque, W; Watson, DJ; Bryant, SG. Death following suspected alprazolam withdrawal seizures: A case report. Texas Medicine. Vol. 86 no. 1. 1990: 44–7. PMID 2300914. 
  64. ^ De Bard, ML. Diazepam withdrawal syndrome: A case with psychosis, seizure, and coma. American Journal of Psychiatry. 1979, 136 (1): 104–5. PMID 103443. doi:10.1176/ajp.136.1.104. 
  65. ^ Provini, F.; Cortelli, P.; Montagna, P.; Gambetti, P.; Lugaresi, E. Fatal insomnia and agrypnia excitata: Sleep and the limbic system. Revue Neurologique. 2008, 164 (8–9): 692–700. PMID 18805303. doi:10.1016/j.neurol.2007.11.003. 
  66. ^ 66.0 66.1 Berezak, A.; Weber, M.; Hansmann, J.; Tulasne, P.A.; Laporte, B.; Ould Ouali, A. Dépendance physique aux benzodiazépines dans un contexte traumatologique [Benzodiazepine physical dependence in traumatology]. Annales Françaises d'Anesthésie et de Réanimation. 1984, 3 (5): 383–4. doi:10.1016/S0750-7658(84)80078-7 （法语）. 
  67. ^ Turkington, Douglas; Gill, Paul. Mania induced by lorazepam withdrawal: A report of two cases. Journal of Affective Disorders. 1989, 17 (1): 93–5. PMID 2525581. doi:10.1016/0165-0327(89)90028-1. 
  68. ^ Lapierre, YD; Labelle, A. Manic-like reaction induced by lorazepam withdrawal. The Canadian Journal of Psychiatry. 1987, 32 (8): 697–8. PMID 3690487. doi:10.1177/070674378703200812. 
  69. ^ Kawajiri, M; Ohyagi, Y; Furuya, H; Araki, T; Inoue, N; Esaki, S; Yamada, T; Kira, J. A patient with Parkinson's disease complicated by hypothyroidism who developed malignant syndrome after discontinuation of etizolam. Rinsho Shinkeigaku. 2002, 42 (2): 136–9. PMID 12424963. 
  70. ^ Strawn, Jeffrey; Keck Jr, PE; Caroff, SN. Neuroleptic Malignant Syndrome. American Journal of Psychiatry. 2007, 164 (6): 870–6. PMID 17541044. doi:10.1176/ajp.2007.164.6.870. 
  71. ^ Khan, A; Joyce, P; Jones, AV. Benzodiazepine withdrawal syndromes. The New Zealand medical journal. 1980, 92 (665): 94–6 [2018-04-05]. PMID 6107888. （原始内容于2019-12-02）. 
  72. ^ Peh, LH; Mahendran, R. Psychiatric complications of Erimin abuse. Singapore medical journal. 1989, 30 (1): 72–3. PMID 2595393. 
  73. ^ Fruensgaard, K. Withdrawal Psychosis: A Study of 30 Consecutive Cases. Acta Psychiatrica Scandinavica. 1976, 53 (2): 105–18. PMID 3091. doi:10.1111/j.1600-0447.1976.tb00065.x. 
  74. ^ Einarson, A; Selby, P; Koren, G. Abrupt discontinuation of psychotropic drugs during pregnancy: Fear of teratogenic risk and impact of counselling. Journal of Psychiatry & Neuroscience. 2001, 26 (1): 44–8. PMC 1408034  . PMID 11212593. 
  75. ^ Citrome, Leslie; Volavka, Jan. Violent Patients in the Emergency Setting. Psychiatric Clinics of North America. 1999, 22 (4): 789–801. PMID 10623971. doi:10.1016/S0193-953X(05)70126-X. 

十月 19, 2023
苯二氮䓬类药物戒斷症候群, 此條目需要擴充, 2018年4月7日, 请協助改善这篇條目, 更進一步的信息可能會在討論頁或扩充请求中找到, 请在擴充條目後將此模板移除, 此條目需要精通或熟悉相关主题的编者参与及协助编辑, 2018年4月7日, 請邀請適合的人士改善本条目, 更多的細節與詳情請參见討論頁, 维基百科中的醫學内容仅供参考, 並不能視作專業意見, 如需獲取醫療幫助或意見, 请咨询专业人士, 詳見醫學聲明, 又称苯二氮卓戒断综合征, 英語, benzodiazepine, withdrawal, syndro. 此條目需要擴充 2018年4月7日 请協助改善这篇條目 更進一步的信息可能會在討論頁或扩充请求中找到 请在擴充條目後將此模板移除 此條目需要精通或熟悉相关主题的编者参与及协助编辑 2018年4月7日 請邀請適合的人士改善本条目 更多的細節與詳情請參见討論頁 维基百科中的醫學内容仅供参考 並不能視作專業意見 如需獲取醫療幫助或意見 请咨询专业人士 詳見醫學聲明 苯二氮䓬类药物戒斷症候群又称苯二氮卓戒断综合征 英語 Benzodiazepine withdrawal syndrome 通常缩写为苯并戒断 benzo withdrawal 或BZD戒断 BZD withdrawal 是指服用苯二氮䓬类药物 可能因医疗原因或娱乐性原因用药 并产生生理依赖性后 减少用量或停药时产生的藥物戒斷症状 觅药行为或按处方服药均可能导致生理依赖性与药物成瘾 或二者之一 以及因此产生的戒断症状 某些症状可能持续数年 苯二氮䓬类药物戒斷症候群的显著特征症状包括 睡眠障碍 易怒 紧张焦虑 恐慌發作 手颤 发抖 出汗 难以集中精神 意识混乱和认知障碍 记忆减退 恶心干呕 体重下降 心悸 头痛 肌肉疼痛僵硬 知觉变化 幻觉 癲癇發作 思覺失調 1 以及自杀 2 3 此外 这些症状可能时好时坏 每日或每周的严重程度不一 而不是持续稳定好转 4 苯二氮䓬类药物戒斷症候群类型戒断状态 苯二氮䓬类药物依赖性分类和外部资源醫學專科精神病学ICD 10F13 3 持续用药后 编辑此条目的维基数据 苯二氮䓬类戒断症状可能很严重 症状复杂且常常长期持续 5 6 长期使用苯二氮䓬类 即每日用药 持续至少三个月 7 可能有更高的药物依赖风险 8 亦可能造成用量增加 药效降低 增加事故和摔倒的概率 尤其是老年人 9 还可能与认知 10 神经系统和智力损伤有关 11 因此不宜长期使用苯二氮䓬类药物 8 将苯二氮䓬类药物作为短效安眠药使用 在入睡时可能有效 但可能因戒断反应而导致后半段睡眠质量不佳 12 尽管如此 对于长期服用苯二氮䓬类药物者 不应违背其意愿强迫停药 5 苯二氮䓬类戒断可能有重症反应 甚至产生癫痫发作等危及生命的症状 13 尤其是突然戒断或减量过快的大剂量或长期用药者 5 然而逐步减量或相对用量较少的短期用药者亦可能出现重症戒断反应 14 在动物模型中甚至曾有单次大剂量用药后戒断出现重症反应 15 16 少数人会出现遷延性戒斷症狀 英语 post acute withdrawal syndrome 症状可能在戒断后数月甚至数年内持续 维持在亚急性状态 缓慢而逐步的减少药物用量能使遷延性戒斷症狀的出现概率尽可能降低 17 长期使用苯二氮䓬类药物会导致神经适应 降低药物效果 造成耐受和依赖 18 即使是持续服用治疗剂量期间 长期使用苯二氮䓬类药物亦可能引起类似戒断反应的症状 尤其是在服药间隔期 19 停药或减少用量后 用药者即会出现药物戒断症状 直至其生理适应恢复 20 这些反跳症状 英语 Rebound effect 可能与最初服药前的病症相同 亦可能是戒斷症候群的一部分 21 在重症病例中 戒断反应可能会恶化 或与严重的精神疾病相似 如狂躁 精神分裂症 尤其在大剂量用药者中还会出现癲癇重積狀態 22 若不能正确诊断出戒斷症候群 可能会误诊为服药前的疾病复发而需要继续用药 导致戒断失败 重新开始用药 而重新用药往往比之前的剂量更大 22 提高戒断成功率的方法包括 提升对戒断反应的意识 针对用药者的戒断反应严重程度而制定个人化的逐步戒断方法 以及增加其他替代方法辅助 如使用药者安心 参加苯二氮䓬类药物戒断互助小组 这些方法都能有效提高戒断的成功率 23 24 症状和体征 编辑 nbsp 地西泮 其2毫克与5毫克片剂常用于治疗苯二氮䓬类戒断反应 25 nbsp 氯二氮平 英语 Chlordiazepoxide 其5毫克胶囊剂有时可作为地西泮的替代药物 用于治疗苯二氮䓬类戒断反应 氯二氮平与地西泮都有较长的消除半衰期和长效活性代謝產物 苯二氮䓬类 巴比妥类等镇静安眠药物或酒精成瘾者在停用后会产生严重的戒断反应症状 临床成人精神医学手册 显示这些戒断症状比鸦片类药物的戒断症状更严重 危害更大 26 使用者在停药时一般甚少获得相关建议和支持 27 一些戒断症状与用药治疗之前的病症相同 21 可能症状严重或长期持续 半衰期较长的苯二氮䓬类药物可能在停用长达三周之后才会出现戒断反应 而半衰期较短的药物则较早出现戒断反应 一般在停用24 48小时后即会出现 28 不同剂量用药者的戒断症状种类可能没有重大差异 但大剂量用药者的症状严重程度往往更高 29 在用药量减少时 服药者可能会首次出现戒断反应 包括失眠 焦虑 痛苦 体重下降 晕眩 夜汗 肌肉抽搐 恐慌发作 抑郁 失实症 偏执等 这些症状更常见于短效苯二氮䓬类停药时 例如三唑仑等药物 22 30 日间症状可能在夜间用药给药数日至数周后出现 31 32 亦可能出现于佐匹克隆等Z药物使用者 33 即使是间歇服用苯二氮䓬类 34 亦可能在戒断后出现失眠症状反弹 可能比服药前更加严重 35 36 逐步或突然减少药量可能出现下列症状 靜坐不能 激动 焦虑 25 可能有惊恐及恐慌發作 1 37 视力模糊 37 胸痛 37 人格解體 38 抑郁 可能严重 39 甚至有自杀念头 2 3 失實症 40 瞳孔放大 22 頭暈 37 口乾 37 煩躁 41 42 血壓升高 43 或高血壓 44 疲勞 虛弱 37 胃肠功能紊乱 包括恶心 腹泻 呕吐等 45 46 46 47 听觉障碍 37 头痛 1 潮熱 发冷 37 嗅覺過敏 英语 Hyperosmia 48 入睡前幻觉 英语 Hypnagogia 17 疑病症 37 触觉敏感度增强 40 排尿频率增加 37 失眠 45 记忆力和专注力受损 1 37 食欲不振 體重下降 49 轻微至中度失语症 48 情绪波动 英语 Mood swings 37 肌肉痉挛 抽筋 不适或肌束震颤 英语 fasciculation 50 梦魇 45 强迫症 51 52 感觉异常 英语 Paraesthesia 37 40 48 5 53 偏执 48 出汗 1 畏光 48 姿位性低血壓 45 快速动眼期睡眠反弹 英语 REM sleep rebound 54 不寧腿綜合症 24 关节僵硬 37 味觉和嗅觉障碍 37 心跳过速 55 耳鸣 56 顫抖 57 58 视觉障碍 40 迅速停药可能会引发更严重的症状 紧张性抑郁障碍 可能致死 59 60 61 意识错乱 英语 Confusion 25 癲癇發作 25 可能致死 62 63 昏迷 64 罕见 震顫性譫妄 65 66 66 高熱 45 狂躁 67 68 抗精神藥物惡性症候群 英语 Neuroleptic malignant syndrome 类似表现 69 70 罕见 器质性脑病综合征 英语 Organic brain syndrome 71 創傷後壓力症候群 24 思覺失調 72 73 自殺意念 英语 Suicidal ideation 74 或自杀 2 3 暴力 攻击行为 37 75 参考来源 编辑 1 0 1 1 1 2 1 3 1 4 Petursson H The benzodiazepine withdrawal syndrome Addiction 1994 89 11 1455 9 PMID 7841856 doi 10 1111 j 1360 0443 1994 tb03743 x 2 0 2 1 2 2 Colvin Rod Overcoming Prescription Drug Addiction A Guide to Coping and Understanding 3 United States of America Addicus Books 26 August 2008 74 76 ISBN 978 1 886039 88 9 I have treated ten thousand patients for alcohol and drug problems and have detoxed approximately 1 500 patients for benzodiazepines the detox for the benzodiazepines is one of the hardest detoxes we do It can take an extremely long time about half the length of time they have been addicted the ongoing relentless withdrawals can be so incapacitating it can cause total destruction to one s life marriages break up businesses are lost bankruptcy hospitalization and of course suicide is probably the most single serious side effect 3 0 3 1 3 2 Dodds TJ Prescribed Benzodiazepines and Suicide Risk A Review of the Literature Primary Care Companion for CNS Disorders 2017 19 2 PMID 28257172 doi 10 4088 PCC 16r02037 C Heather Ashton DM Chapter III Benzodiazepine withdrawal symptoms acute amp protracted Institute of Neuroscience Newcastle University 29 April 2013 原始内容存档于2019 04 04 Benzodiazepines How they work and how to withdraw 5 0 5 1 5 2 5 3 Professor Heather Ashton Benzodiazepines How They Work and How to Withdraw 2002 2018 04 02 原始内容存档于2012 10 18 O Connor RD Benzodiazepine dependence a treatment perspective and an advocacy for control NIDA research monograph 1993 131 266 9 PMID 8105385 Voshaar R C O Couvee JE Van Balkom AJ Mulder PG Zitman FG Strategies for discontinuing long term benzodiazepine use Meta analysis British Journal of Psychiatry 2006 189 3 213 20 PMID 16946355 doi 10 1192 bjp 189 3 213 8 0 8 1 Nutt David Benzodiazepine dependence in the clinic Reason for anxiety Trends in Pharmacological Sciences 1986 7 457 60 doi 10 1016 0165 6147 86 90420 7 De Gier N Gorgels W Lucassen P Oude Voshaar R Mulder J Zitman F Discontinuation of long term benzodiazepine use 10 year follow up Family Practice 2010 28 3 253 9 PMID 21193495 doi 10 1093 fampra cmq113 Authier Nicolas Boucher Alexandra Lamaison Dominique Llorca Pierre Michel Descotes Jacques Eschalier Alain Second Meeting of the French CEIP Centres d Evaluation et d Information sur la Pharmacodependance Part II Benzodiazepine Withdrawal Therapie 2009 64 6 365 70 PMID 20025839 doi 10 2515 therapie 2009051 Heberlein A Bleich S Kornhuber J Hillemacher T Benzodiazepin Abhangigkeit Ursachen und Behandlungsmoglichkeiten Benzodiazepine Dependence Causalities and Treatment Options Fortschritte der Neurologie Psychiatrie 2008 77 1 7 15 PMID 19101875 doi 10 1055 s 0028 1100831 德语 Lee chiong Teofilo Sleep Medicine Essentials and Review Oxford University Press USA 24 April 2008 468 ISBN 0 19 530659 7 Evans Katie Sullivan Michael J Withdrawal and Medical Issues Dual Diagnosis Counseling the Mentally Ill Substance Abuser 2nd Guilford Press 2001 52 3 2018 04 02 ISBN 978 1 57230 446 8 原始内容存档于2018 05 03 Lader M Long term anxiolytic therapy The issue of drug withdrawal The Journal of Clinical Psychiatry 1987 48 Suppl 12 6 PMID 2891684 Boisse NR Periana RM Guarino JJ Kruger HS Samoriski GM Pharmacologic characterization of acute chlordiazepoxide dependence in the rat Journal of Pharmacology and Experimental Therapeutics 1986 239 3 775 83 PMID 3098961 Boisse NR Periana RM Guarino JJ Kruger HS Acute chlordiazepoxide dependence in the rat Comparisons to chronic NIDA research monograph 1986 67 197 201 PMID 3092067 17 0 17 1 Professor Heather Ashton Protracted Withdrawal Symptoms From Benzodiazepines Comprehensive Handbook of Drug amp Alcohol Addiction 2004 2018 04 02 原始内容存档于2020 09 28 引用错误 带有name属性 pwsfb 的 lt ref gt 标签用不同内容定义了多次 Allison C Pratt J A Neuroadaptive processes in GABAergic and glutamatergic systems in benzodiazepine dependence Pharmacology amp Therapeutics 2003 98 2 171 95 PMID 12725868 doi 10 1016 S0163 7258 03 00029 9 Herman JB Brotman AW Rosenbaum JF Rebound anxiety in panic disorder patients treated with shorter acting benzodiazepines The Journal of Clinical Psychiatry 1987 48 Suppl 22 8 PMID 2889722 Allgulander C Bandelow B Hollander E Montgomery SA Nutt DJ Okasha A Pollack MH Stein DJ Swinson RP World Council Of Anxiety WCA recommendations for the long term treatment of generalized anxiety disorder CNS Spectrums 2003 8 8 Suppl 1 53 61 PMID 14767398 21 0 21 1 Salzman Carl Benzodiazepine treatment of panic and agoraphobic symptoms Use dependence toxicity abuse Journal of Psychiatric Research 1993 27 97 110 PMID 7908335 doi 10 1016 0022 3956 93 90021 S 22 0 22 1 22 2 22 3 Gabbard Glen O Gabbard s Treatments of Psychiatric Disorders Fourth Edition Treatments of Psychiatric Disorders American Psychiatric Publishing 15 May 2007 209 211 ISBN 1 58562 216 8 Onyett SR The benzodiazepine withdrawal syndrome and its management The Journal of the Royal College of General Practitioners 1989 39 321 160 3 PMC 1711840 nbsp PMID 2576073 24 0 24 1 24 2 Ashton Heather Protracted withdrawal syndromes from benzodiazepines Journal of Substance Abuse Treatment 1991 8 1 2 19 28 PMID 1675688 doi 10 1016 0740 5472 91 90023 4 25 0 25 1 25 2 25 3 Soyka M Treatment of Benzodiazepine Dependence The New England Journal of Medicine 2017 376 12 1147 1157 PMID 28328330 doi 10 1056 NEJMra1611832 Lindsay S J E The Handbook of Clinical Adult Psychology Psychology Press 1994 363 2018 04 05 ISBN 9780415072168 原始内容存档于2019 09 05 Authier N Balayssac D Sautereau M Zangarelli A Courty P Somogyi A A Vennat B Llorca P M Eschalier A Benzodiazepine dependence Focus on withdrawal syndrome Annales pharmaceutiques francaises 2009 67 6 408 13 PMID 19900604 doi 10 1016 j pharma 2009 07 001 Committee on Safety of Medicines Hypnotics and anxiolytics British National Formulary 2007 17 September 2007 nbsp Murphy S M Tyrer P A double blind comparison of the effects of gradual withdrawal of lorazepam diazepam and bromazepam in benzodiazepine dependence British Journal of Psychiatry 1991 158 4 511 6 PMID 1675901 doi 10 1192 bjp 158 4 511 Adam Kirstine Oswald I Can a Rapidly eliminated Hypnotic Cause Daytime Anxiety Pharmacopsychiatry 2008 22 3 115 9 PMID 2748714 doi 10 1055 s 2007 1014592 Scharf Martin B Kales Judith A Bixler EO Jacoby JA Schweitzer PK Lorazepam Efficacy side effects and rebound phenomena Clinical Pharmacology amp Therapeutics 1982 31 2 175 9 PMID 6120058 doi 10 1038 clpt 1982 27 Walsh James K Schweitzer Paula K Parwatikar Sadashiv Effects of lorazepam and its withdrawal on sleep performance and subjective state Clinical Pharmacology amp Therapeutics 1983 34 4 496 500 PMID 6617072 doi 10 1038 clpt 1983 203 Fontaine Rejean Beaudry Paul Le Morvan Patrick LE Beauclair Linda Chouinard GUY Zopiclone and Triazolam in Insomnia Associated with Generalized Anxiety Disorder International Clinical Psychopharmacology 1990 5 3 173 83 PMID 2230061 doi 10 1097 00004850 199007000 00002 Kales Anthony Manfredi Rocco L Vgontzas Alexandras N Bixler Edward O Vela Bueno Antonio Fee Eric C Rebound insomnia after only brief and intermittent use of rapidly eliminated benzodiazepines Clinical Pharmacology amp Therapeutics 1991 49 4 468 76 PMID 2015735 doi 10 1038 clpt 1991 55 Kales Anthony Bixler Edward O Soldatos Constantin R Jacoby Judith A Kales Joyce D Lorazepam Effects on Sleep and Withdrawal Phenomena Pharmacology 1986 32 3 121 30 PMID 3960963 doi 10 1159 000138160 Bonnet M H Arand D L The use of lorazepam TID for chronic insomnia International Clinical Psychopharmacology 1999 14 2 81 9 PMID 10220122 doi 10 1097 00004850 199903000 00004 37 00 37 01 37 02 37 03 37 04 37 05 37 06 37 07 37 08 37 09 37 10 37 11 37 12 37 13 37 14 37 15 Saxon L Hjemdahl P Hiltunen A J Borg S Effects of flumazenil in the treatment of benzodiazepine withdrawal a double blind pilot study Psychopharmacology 1997 131 2 153 60 PMID 9201803 doi 10 1007 s002130050278 Terao T Yoshimura R Terao M Abe K Depersonalization following nitrazepam withdrawal Biological Psychiatry 1992 31 2 212 3 PMID 1737083 doi 10 1016 0006 3223 92 90209 I Lader Malcolm Anxiety or depression during withdrawal of hypnotic treatments Journal of Psychosomatic Research 1994 38 113 23 discussion 118 23 PMID 7799243 doi 10 1016 0022 3999 94 90142 2 40 0 40 1 40 2 40 3 Mintzer M Z Stoller K B Griffiths R R A controlled study of flumazenil precipitated withdrawal in chronic low dose benzodiazepine users Psychopharmacology 1999 147 2 200 9 PMID 10591888 doi 10 1007 s002130051161 Mendelson WB Weingartner H Greenblatt DJ Garnett D Gillin JC A clinical study of flurazepam Sleep 1982 5 4 350 60 PMID 6761826 Schopf J Withdrawal Phenomena after Long term Administration of Benzodiazepines a Review of Recent Investigations Pharmacopsychiatry 2008 16 1 1 8 PMID 6131447 doi 10 1055 s 2007 1017439 Mintzer Miriam Z Griffiths Roland R Flumazenil precipitated withdrawal in healthy volunteers following repeated diazepam exposure Psychopharmacology 2004 178 2 3 259 67 PMID 15452683 doi 10 1007 s00213 004 2009 1 Biswas AK Feldman BL Davis DH Zintz EA Myocardial ischemia as a result of severe benzodiazepine and opioid withdrawal Clinical Toxicology 2005 43 3 207 9 PMID 15902797 doi 10 1081 clt 200053099 45 0 45 1 45 2 45 3 45 4 Bismuth C Le Bellec M Dally S Lagier G Benzodiazepine physical dependence 6 cases author s transl La Nouvelle presse medicale 1980 9 28 1941 5 PMID 6106922 46 0 46 1 Loeb P Adnet P Boittiaux P Forget AP Mille FX Sevrage en benzodiazepines revele par un syndrome douloureux abdominal pseudochirurgical Benzodiazepine withdrawal masquerading as surgical abdominal syndrome Annales Francaises d Anesthesie et de Reanimation 1997 16 5 521 2 doi 10 1016 S0750 7658 97 83345 X 法语 BENZODIAZEPINE WITHDRAWAL SYMPTOMS ACUTE AND PROTRACTED Benzo org uk 2018 04 05 原始内容存档于2019 04 04 48 0 48 1 48 2 48 3 48 4 Pelissolo A Bisserbe JC Dependence on benzodiazepines Clinical and biological aspects L Encephale 1994 20 2 147 57 PMID 7914165 Pecknold J C Discontinuation reactions to alprazolam in panic disorder Journal of Psychiatric Research 1993 27 155 170 doi 10 1016 0022 3956 93 90025 W Kliniska Fardigheter Informationsutbytet Mellan Patient Och Lakare LINDGREN STEFAN ISBN 91 44 37271 X Swedish 页码请求 Drummond Lynne M Matthews Helen P SINGLE CASE STUDY Obsessive Compulsive Disorder Occurring as a Complication in Benzodiazepine Withdrawal Journal of Nervous and Mental Disease 1988 176 11 688 91 PMID 3183654 doi 10 1097 00005053 198811000 00008 Matthews HP Drummond LM Obsessive compulsive disorder a complication of benzodiazepine withdrawal British Journal of Psychiatry 1987 150 272 PMID 3651695 doi 10 1192 s0007125000122810 Shader RI Greenblatt DJ The use of benzodiazepines in clinical practice British Journal of Clinical Pharmacology 1981 11 Suppl 1 Suppl 1 5S 9S PMC 1401641 nbsp PMID 6133535 doi 10 1111 j 1365 2125 1981 tb01832 x Pagel J F Parnes Bennett L Medications for the Treatment of Sleep Disorders Primary Care Companion to the Journal of Clinical Psychiatry 2001 3 3 118 125 PMC 181172 nbsp PMID 15014609 doi 10 4088 PCC v03n0303 Van Engelen BG Gimbrere JS Booy LH Benzodiazepine withdrawal reaction in two children following discontinuation of sedation with midazolam Annals of Pharmacotherapy 1993 27 5 579 81 PMID 8347907 doi 10 1177 106002809302700509 Beeley L Benzodiazepines and tinnitus BMJ 1991 302 6790 1465 doi 10 1136 bmj 302 6790 1465 Mellor CS Jain VK Diazepam withdrawal syndrome Its prolonged and changing nature Canadian Medical Association Journal 1982 127 11 1093 6 PMC 1862031 nbsp PMID 7139456 Olajide Dele Lader Malcolm Depression following withdrawal from long term benzodiazepine use A report of four cases Psychological Medicine 2009 14 4 937 40 PMID 6152745 doi 10 1017 S0033291700019899 Rosebush Patricia I Mazurek Michael F Catatonia After Benzodiazepine Withdrawal Journal of Clinical Psychopharmacology 1996 16 4 315 9 PMID 8835707 doi 10 1097 00004714 199608000 00007 Deuschle M F Lederbogen F Benzodiazepine Withdrawal Induced Catatonia Pharmacopsychiatry 2001 34 1 41 2 PMID 11229621 doi 10 1055 s 2001 15188 Kanemoto Kousuke Miyamoto Toshio Abe Ryuji Ictal catatonia as a manifestation of de novo absence status epilepticus following benzodiazepine withdrawal Seizure 1999 8 6 364 6 PMID 10512781 doi 10 1053 seiz 1999 0309 Metten Pamela Crabbe John C Genetic Determinants of Severity of Acute Withdrawal from Diazepam in Mice Pharmacology Biochemistry and Behavior 1999 63 3 473 9 PMID 10418790 doi 10 1016 S0091 3057 99 00017 9 Haque W Watson DJ Bryant SG Death following suspected alprazolam withdrawal seizures A case report Texas Medicine Vol 86 no 1 1990 44 7 PMID 2300914 De Bard ML Diazepam withdrawal syndrome A case with psychosis seizure and coma American Journal of Psychiatry 1979 136 1 104 5 PMID 103443 doi 10 1176 ajp 136 1 104 Provini F Cortelli P Montagna P Gambetti P Lugaresi E Fatal insomnia and agrypnia excitata Sleep and the limbic system Revue Neurologique 2008 164 8 9 692 700 PMID 18805303 doi 10 1016 j neurol 2007 11 003 66 0 66 1 Berezak A Weber M Hansmann J Tulasne P A Laporte B Ould Ouali A Dependance physique aux benzodiazepines dans un contexte traumatologique Benzodiazepine physical dependence in traumatology Annales Francaises d Anesthesie et de Reanimation 1984 3 5 383 4 doi 10 1016 S0750 7658 84 80078 7 法语 Turkington Douglas Gill Paul Mania induced by lorazepam withdrawal A report of two cases Journal of Affective Disorders 1989 17 1 93 5 PMID 2525581 doi 10 1016 0165 0327 89 90028 1 Lapierre YD Labelle A Manic like reaction induced by lorazepam withdrawal The Canadian Journal of Psychiatry 1987 32 8 697 8 PMID 3690487 doi 10 1177 070674378703200812 Kawajiri M Ohyagi Y Furuya H Araki T Inoue N Esaki S Yamada T Kira J A patient with Parkinson s disease complicated by hypothyroidism who developed malignant syndrome after discontinuation of etizolam Rinsho Shinkeigaku 2002 42 2 136 9 PMID 12424963 Strawn Jeffrey Keck Jr PE Caroff SN Neuroleptic Malignant Syndrome American Journal of Psychiatry 2007 164 6 870 6 PMID 17541044 doi 10 1176 ajp 2007 164 6 870 Khan A Joyce P Jones AV Benzodiazepine withdrawal syndromes The New Zealand medical journal 1980 92 665 94 6 2018 04 05 PMID 6107888 原始内容存档于2019 12 02 Peh LH Mahendran R Psychiatric complications of Erimin abuse Singapore medical journal 1989 30 1 72 3 PMID 2595393 Fruensgaard K Withdrawal Psychosis A Study of 30 Consecutive Cases Acta Psychiatrica Scandinavica 1976 53 2 105 18 PMID 3091 doi 10 1111 j 1600 0447 1976 tb00065 x Einarson A Selby P Koren G Abrupt discontinuation of psychotropic drugs during pregnancy Fear of teratogenic risk and impact of counselling Journal of Psychiatry amp Neuroscience 2001 26 1 44 8 PMC 1408034 nbsp PMID 11212593 Citrome Leslie Volavka Jan Violent Patients in the Emergency Setting Psychiatric Clinics of North America 1999 22 4 789 801 PMID 10623971 doi 10 1016 S0193 953X 05 70126 X 取自 https zh wikipedia org w index php title 苯二氮䓬类药物戒斷症候群 amp oldid 70834854, 维基百科，wiki，书籍，书籍，图书馆，

文章

，阅读，下载，免费，免费下载，mp3，视频，mp4，3gp， jpg，jpeg，gif，png，图片，音乐，歌曲，电影，书籍，游戏，游戏。